Krystal Biotech Ownership | Who Owns Krystal Biotech?

Overview Forecast RevenueFinancials Chart Transcripts

Krystal Biotech Ownership Summary

Krystal Biotech is owned by 41.52% institutional investors, 11.14% insiders, and 47.33% retail investors. Fmr is the largest institutional shareholder, holding 15.11% of KRYS shares. Fidelity Select Biotechnology is the top mutual fund, with 6.11% of its assets in Krystal Biotech shares.

KRYS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Krystal Biotech	41.52%	11.14%	47.33%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Biotech Stocks	35.43%	12.01%	52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	4.37M	15.11%	$1.13B
Blackrock funding, inc. /de	4.18M	14.28%	$1.55B
Blackrock	3.95M	13.95%	$724.98M
Avoro capital advisors	2.89M	9.98%	$746.26M
Vanguard group	2.78M	9.60%	$685.10M
State street	1.35M	4.61%	$502.20M
Soleus capital management	939.25K	3.21%	$349.09M
Capital world investors	777.84K	2.66%	$289.10M
Vestor capital	700.91K	2.39%	$78.19M
Geode capital management	698.99K	2.39%	$259.84M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Soleus capital management	939.25K	12.03%	$349.09M
Redmile group	673.50K	11.52%	$173.98M
Act capital management	45.00K	10.93%	$16.73M
S squared	86.22K	8.43%	$22.27M
Avoro capital advisors	2.89M	7.34%	$746.26M
Palisades investment partners	47.80K	5.05%	$17.77M
Vestor capital	700.91K	4.91%	$78.19M
Evolutionary tree capital management	16.81K	4.81%	$4.14M
Frazier life sciences management	481.31K	3.20%	$124.33M
Bellevue group	481.79K	2.96%	$124.45M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	3.95M	0.02%	2.14M
Vestor capital	700.91K	4.91%	700.71K
Norges bank	259.03K	0.01%	259.03K
Blackrock funding, inc. /de	4.18M	0.02%	240.98K
Invesco	251.37K	0.01%	191.37K

Top Sellers

Holder	Shares	% Assets	Change
Citadel advisors	2.73K	0.00%	-383.78K
Soleus capital management	939.25K	12.03%	-213.83K
T. rowe price investment management	-	-	-185.55K
Baker bros. advisors lp	-	-	-169.93K
Lord, abbett	-	-	-151.22K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	259.03K	0.01%	259.03K	$96.27M
Vanguard fiduciary trust	179.16K	0.01%	179.16K	$46.28M
Westfield capital management co lp	98.71K	0.12%	98.71K	$36.69M
Eagle asset management	76.26K	0.07%	76.26K	$13.90M
Congress asset management co /ma	40.13K	0.09%	40.13K	$14.92M

Sold Out

Holder	Change
Kilter group	-1.00
Tradewinds capital management	-1.00
Tortoise investment management	-1.00
Tfc financial management	-1.00
Mendota financial group	-2.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	234	-31.78%	12,018,941	-57.72%	41	0.43%	135	-30.77%	60	-43.40%
Dec 31, 2025	232	-22.15%	16,100,358	-42.52%	55	0.59%	128	-16.88%	74	-12.94%
Sep 30, 2025	289	4.33%	27,787,336	3.78%	96	1.12%	149	7.19%	83	-10.75%
Jun 30, 2025	280	-10.26%	27,626,558	1.12%	95	1.06%	140	-8.50%	94	-16.07%
Mar 31, 2025	310	9.54%	27,310,084	-1.64%	94	1.01%	152	13.43%	111	12.12%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Select Biotechnology	1.80M	6.11%	-
iShares Core S&P Small-Cap ETF	1.58M	5.36%	222.00
Fidelity Growth Compy Commingled Pl S	1.07M	3.62%	20.90K
Fidelity Growth Compy Commingled Pl O	915.43K	3.19%	-
iShares Core S&P Mid-Cap ETF	901.22K	3.04%	28.00
Vanguard Total Stock Mkt Idx Inv	889.73K	3.02%	51.28K
Vanguard Morn Total Stk Mkt Idx Investor	889.73K	3.02%	51.28K
Vanguard US Total Market Shares ETF	824.72K	2.86%	704.00
Fidelity Growth Company Fund	805.13K	2.72%	16.61K
American Funds SMALLCAP World A	752.24K	2.55%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 25, 2026	Thomas John Charles	EVP, General Counsel	Sell	$347.27K
Jun 04, 2026	Krishnan Suma	President, R&D	Sell	$74.88K
Jun 04, 2026	Krishnan Suma	President, R&D	Sell	$179.23K
Jun 04, 2026	Krishnan Suma	President, R&D	Sell	$96.24K
Jun 04, 2026	Krishnan Suma	President, R&D	Sell	$121.96K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	24
2026 Q1	-	52
2025 Q4	-	32
2025 Q3	-	30
2025 Q2	-	-

KRYS Ownership FAQ

Who Owns Krystal Biotech?

Krystal Biotech shareholders are primarily institutional investors at 41.52%, followed by 11.14% insiders and 47.34% retail investors. The average institutional ownership in Krystal Biotech's industry, Biotech Stocks , is 35.43%, which Krystal Biotech exceeds.

Who owns the most shares of Krystal Biotech?

Krystal Biotech’s largest shareholders are Fmr (4.37M shares, 15.11%), Blackrock funding, inc. /de (4.18M shares, 14.28%), and Blackrock (3.95M shares, 13.95%). Together, they hold 43.34% of Krystal Biotech’s total shares outstanding.

Does Blackrock own Krystal Biotech?

Yes, BlackRock owns 13.95% of Krystal Biotech, totaling 3.95M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 724.98M$. In the last quarter, BlackRock increased its holdings by 2.14M shares, a 118.67% change.

Who is Krystal Biotech’s biggest shareholder by percentage of total assets invested?

Soleus capital management is Krystal Biotech’s biggest shareholder by percentage of total assets invested, with 12.03% of its assets in 939.25K Krystal Biotech shares, valued at 349.09M$.

Who is the top mutual fund holder of Krystal Biotech shares?

Fidelity Select Biotechnology is the top mutual fund holder of Krystal Biotech shares, with 6.11% of its total shares outstanding invested in 1.8M Krystal Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools